News Biogen’s Alzheimer’s drug, elenbecestat, shows early promise A trial of Biogen’s Alzheimer’s disease drug elenbecestat has had promising results in mild to moderate forms of the disease.
News vTv's azeliragon is latest Alzheimer's drug failure vTv to stop all studies after STEADFAST trial failure
AbbVie Biogen gets go-ahead for EU Humira launch in October But deal with Samsung prevents US launch until mid-2023
News Dangerous inflammation prompts worldwide withdrawal of MS dr... Biogen and AbbVie have announced the voluntary withdrawal of their multiple sclerosis drug Zinbryta from all markets worldwide following dangerous brain inflammation in seven patients in Eu
News Concerns mount over Biogen Alzheimer's drug FDA announces guidance to encourage development of new drugs
News Boehringer latest to axe Alzheimer's drug Company will trial BI 409306 in schizophrenia instead.
News Europe is facing a surge in STIs, says ECDC Cases of sexually-transmitted infections (STIs) – particularly gonorrhoea and syphilis – are at record levels across 29 European countries.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
